Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer

Publication

Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer

Journal Paper/Review - Sep 13, 2021

Stoll Susanna, Unger Sheila, Azzarello-Burri Silvia, Chappuis Pierre, Graffeo Rossella, Pichert Gabriella, Röthlisberger Benno, Taban Francois, Riniker Salome

Citation

Stoll S, Unger S, Azzarello-Burri S, Chappuis P, Graffeo R, Pichert G, Röthlisberger B, Taban F, Riniker S. Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer. Swiss Med Wkly 2021; 151:w30038.

Type

Journal Paper/Review (English)

Journal

Swiss Med Wkly 2021; 151

Publication Date

Sep 13, 2021

Issn Electronic

1424-3997

Pages

w30038

Brief description/objective

This paper presents the Swiss guideline for genetic counselling and testing of individuals with an increased probability for carrying mutations in high risk cancer predisposition genes, particularly BRCA1 and BRCA2. It aims to help providers of genetic counselling to identify valuable candidates for testing and serves as a basis for reimbursement claims to Swiss insurance companies.